A deep dive into the Asian generic pharmaceutical landscape, comparing India's volume dominance with China's API control and the rise of emerging hubs.
Apr, 22 2026
Mar, 23 2026
Feb, 25 2026
Dec, 1 2025
Aug, 26 2025